Literature DB >> 33682765

Cancer classification and biomarker selection via a penalized logsum network-based logistic regression model.

Zhiming Zhou1, Haihui Huang1,2, Yong Liang3.   

Abstract

BACKGROUND: In genome research, it is particularly important to identify molecular biomarkers or signaling pathways related to phenotypes. Logistic regression model is a powerful discrimination method that can offer a clear statistical explanation and obtain the classification probability of classification label information. However, it is unable to fulfill biomarker selection.
OBJECTIVE: The aim of this paper is to give the model efficient gene selection capability.
METHODS: In this paper, we propose a new penalized logsum network-based regularization logistic regression model for gene selection and cancer classification.
RESULTS: Experimental results on simulated data sets show that our method is effective in the analysis of high-dimensional data. For a large data set, the proposed method has achieved 89.66% (training) and 90.02% (testing) AUC performances, which are, on average, 5.17% (training) and 4.49% (testing) better than mainstream methods.
CONCLUSIONS: The proposed method can be considered a promising tool for gene selection and cancer classification of high-dimensional biological data.

Entities:  

Keywords:  Regularization; gene selection; log-sum penalty; network-based knowledge

Year:  2021        PMID: 33682765     DOI: 10.3233/THC-218026

Source DB:  PubMed          Journal:  Technol Health Care        ISSN: 0928-7329            Impact factor:   1.285


  3 in total

1.  Big data and artificial intelligence (AI) methodologies for computer-aided drug design (CADD).

Authors:  Jai Woo Lee; Miguel A Maria-Solano; Thi Ngoc Lan Vu; Sanghee Yoon; Sun Choi
Journal:  Biochem Soc Trans       Date:  2022-02-28       Impact factor: 4.919

2.  Integrating molecular interactions and gene expression to identify biomarkers and network modules of chronic obstructive pulmonary disease.

Authors:  Hai-Hui Huang; Yong Liang
Journal:  Technol Health Care       Date:  2022       Impact factor: 1.205

3.  Integrating molecular interactions and gene expression to identify biomarkers to predict response to tumor necrosis factor inhibitor therapies in rheumatoid arthritis patients.

Authors:  Min-Fan He; Yong Liang; Hai-Hui Huang
Journal:  Technol Health Care       Date:  2022       Impact factor: 1.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.